|
Volumn 43, Issue 3, 2007, Pages 183-189
|
Stents in interventional cardiology;Kraujagysliu pletikliai intervencineje kardiologijoje.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIINFECTIVE AGENT;
ANTIINFLAMMATORY AGENT;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
DRUG DERIVATIVE;
FIBRINOLYTIC AGENT;
IMMUNOSUPPRESSIVE AGENT;
PREDNISOLONE;
RAPAMYCIN;
TICLOPIDINE;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY THROMBOSIS;
DIABETES MELLITUS;
DRUG COMBINATION;
DRUG DELIVERY SYSTEM;
FOLLOW UP;
HUMAN;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
REVIEW;
RISK FACTOR;
STANDARD;
STENT;
TIME;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTI-BACTERIAL AGENTS;
ANTI-INFLAMMATORY AGENTS;
ASPIRIN;
CORONARY RESTENOSIS;
CORONARY THROMBOSIS;
DIABETES COMPLICATIONS;
DRUG DELIVERY SYSTEMS;
DRUG THERAPY, COMBINATION;
FIBRINOLYTIC AGENTS;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
PREDNISOLONE;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SIROLIMUS;
STENTS;
TICLOPIDINE;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 34247606775
PISSN: None
EISSN: 16489144
Source Type: Journal
DOI: 10.3390/medicina43030022 Document Type: Review |
Times cited : (6)
|
References (27)
|